Skip to main content
. 2017 Feb 11;36(5):1005–1012. doi: 10.1007/s10067-017-3570-4

Fig. 1.

Fig. 1

a Concentration of RANKL in patients and control subjects. b Concentration of RANKL in patients stratified for anti-CCP2 antibodies